European Urology

Papers
(The H4-Index of European Urology is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Manfred Wirth – A life devoted to urology in a time of change1080
Editorial Board1038
Congress Calendar576
Contents496
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination The494
Editorial Board480
Re: Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes461
Contents450
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer345
Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell Carcinoma334
Putting Precision Medicine in Prostate Cancer into Practice: Are We There Yet?310
Contents285
Congress Calendar242
Reply to Laurence Klotz’s Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of “Manels” in Major Urology219
Re: Unplanned Conversion from Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors218
Photodynamic diagnosis (PDD) directed biopsies vs white light bladder mapping in patients with positive cytology and negative preoperative workup: An international multicenter retrospective study. On 202
Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma173
Use cluster analysis to develop an accurate and practical diagnostic method for detrusor underactivity in female patient without bladder outlet obstruction168
A comprehensive in vitro assessment of thulium fiber laser in soft tissues and stones162
Minimally invasive adrenalectomy for the treatment of malignant adrenal metastasis: Results from two high volume centers152
Transcriptomic analysis of the lncRNA-miRNA-mRNA axis network in aldosterone-producing adenoma148
Robot-assisted radical prostatectomy for prostate cancer: 18-year oncological outcomes from a Belgian high-volume center144
Surgical outcomes of robot-assisted radical prostatectomy with the novel HUGO™ robotic system: Initial 100 cases performed at a tertiary referral robotic center143
Patient-derived organoids represent intra- and interindividual heterogeneity in castration-resistant prostate cancer122
Functional and endoscopic results up to two years after Aquablation for BPH-related LUTS: A single centre first clinical experience122
Protein-based molecular subtypes associate with clinical-pathological characteristics in a multi-institutional cohort of upper tract urothelial carcinomas120
What are the optimal laser settings for stone dusting using the popcorn technique113
Clinicopathological correlate of urine 8-hydroxydeoxyguanosine levels in patients with prostate biopsy112
Cumulative thulium fiber laser energy and stone-free rates: Outcomes from the team of worldwide endourological researchers (TOWER) thulium fiber laser registry112
AI-based classification and segmentation method for bladder cancer from cystoscopic image: Preliminary study111
Quantitative MRI parameters providing the novel value in discriminating muscle-invasive bladder cancer107
Urolithiasis in patients with kidney transplantation: Multicenter KSER research series105
Epidermal growth factor-like domain 7 inhibit immune response in metastatic castration resistant prostate cancer by de-activation of endothelial intercellular adhesion molecule-1103
Igloo-technique for robotic radical prostatectomy — maximum nerve sparing for early recovery of continence and sexual function103
Development and validation of a new personalized algorithmic model for PSA analysis : PROSTia103
Comparison of two different approaches in the management of infants with primaryobstructive megaureters and their long-term outcomes97
Utility of robotic platform for upper and mid ureteric reconstruction: Our experience at MPUH, Nadiad96
More micrometastases, more recurrence? Assessing the role of quantitative rtPCR of PSA from lymph nodes post-prostatectomy in predicting biochemical recurrence - an experimental study95
Assessing the potential of cystatin 4 as a blood biomarker for prostate cancer diagnosis and prognosis: A prospective single-center study93
The impact of adjuvant chemotherapy on overall survival in patients with node-positive Upper Tract Urothelial Carcinoma (UTUC): Improving precision in medicine with a risk-stratified approach91
Prostate cancer prevention clinic for men with risk of familial prostate cancer (profam-risk)90
Management of renal cell carcinoma in transplant kidney: An individual patient data meta-analysis and evidence-based guide89
Incontinence in boys and girls following succesful primary closure of bladder extrophy: Management with orthotopic ileal neobladder and costruction of anterior intrapelvic neourethra derived from detr88
The effect of duration between sessions on biofeedback treatment in children with dysfunctional voiding88
Is testosterone replacement therapy effective and safe even for eugonadal men with symptom of late onset hypogonadism?87
Radiomics-based prognostic model guided by artificial intelligence to predict lymph node invasion and biochemical recurrence in patients with high-grade prostate cancer87
Retzius-sparing robot-assisted radical prostatectomy for large prostate volumes: Surgical and functional outcomes84
Replacing ReTUR with Cystoscopy in High-Grade T1 NMIBC patients: Confirmatory results from the HuNIRe Trial84
Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study83
Single-port vs. multi-port robot-assisted partial nephrectomy: A single center propensity-score matched analysis82
Impact of radical prostatectomy on pelvic floor muscles: An electromyography and perineometric assessment80
Comparing PSA screening patterns and their role as predictor of prostate cancer incidence and mortality: A system wide analysis of a contemporary North American cohort80
The next generation trial: Assessing 18F-PSMA-1007 positron emission tomography and magnetic resonance imaging in the primary staging of prostate cancer patients78
Re: Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer77
Epidemiological outcomes in immunocompromised vs. immunocompetent prostate cancer patients: A systematic review, meta-analysis and meta-regression76
A randomized controlled trial comparing 1470nm diode laser vs. plasmakinetic enucleation of the prostate for treating benign prostatic hyperplasia75
The surgical learning curve for cancer control after robot-assisted radical prostatectomy75
Outcomes according to histological variants of urothelial carcinoma after neoadjuvant chemotherapy in the GETUG-AFU V05 VESPER trial75
Delayed absent ejaculation in men presenting to the fertility clinic – retrospective cohort study75
Sutureless robot assisted partial nephrectomy: Feasibility and surgical technique (UroCCR n°158)72
Strengths and weaknesses of using Optum Clinformatics Data Mart to study in-vitro fertilization71
Efficacy and safety of low-dose tadalafil compared to tolterodine and placebo in females with overactive bladder symptoms. A prospective double blind controlled study70
MRI/US fusion targeted prostate biopsies koelis®: Impact of operator experience on clinicaly significant prostate cancer detection69
Qualitative assessment of patient-reported outcomes in urinary and sexual function in patient after perineal urethrostomy69
Propensity-score matched survival analysis of octogenarians with muscle-invasive bladder cancer: Chemoradiation compared to radical cystectomy69
Short-term morbidity and long-term functional outcomes of the T-plasty for salvage reconstruction of recalcitrant bladder neck stenosis69
Incidental prostate cancer in patients treated for benign prostatic hyperplasia: Analysis from a contemporary national dataset68
0.20425391197205